Pactum AS, a closely related party to the primary insider and board member Espen W. Marcussen in Vistin Pharma ASA, has on 29 October 2021 sold 3,519,733 shares in Vistin Pharma ASA at NOK 19.50 per share to its wholly-owned subsidiary Pactum Vekst AS in connection with an internal reorganization of Pactum AS. Pactum Vekst AS is also a closely related party to the primary insider and board member Espen W. Marcussen in Vistin Pharma ASA.
Please refer to the attached notifications of trading for further details.
Attachments
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…
MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…
Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…
PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…
BELFAST, Northern Ireland , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…